These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34879432)

  • 1. Transglutaminase 2: Development of therapeutic antibodies reveals four inhibitory epitopes and confirms extracellular function in fibrotic remodelling.
    Maamra M; Benayad OM; Matthews D; Kettleborough C; Atkinson J; Cain K; Bon H; Brand H; Parkinson M; Watson PF; Johnson TS
    Br J Pharmacol; 2022 Jun; 179(11):2697-2712. PubMed ID: 34879432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of TG2-inhibitory monoclonal antibody zampilimab on tissue fibrosis in human in vitro and primate in vivo models of chronic kidney disease.
    Huang L; Bon H; Maamra M; Holmes T; Atkinson J; Cain K; Kennedy J; Kettleborough C; Matthews D; Twomey B; Ni J; Song Z; Watson PF; Johnson TS
    PLoS One; 2024; 19(5):e0298864. PubMed ID: 38753630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain.
    Chou CY; Streets AJ; Watson PF; Huang L; Verderio EA; Johnson TS
    J Biol Chem; 2011 Aug; 286(31):27825-35. PubMed ID: 21652693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between transglutaminases and heparan sulphate in progressive renal scarring.
    Burhan I; Furini G; Lortat-Jacob H; Atobatele AG; Scarpellini A; Schroeder N; Atkinson J; Maamra M; Nutter FH; Watson P; Vinciguerra M; Johnson TS; Verderio EA
    Sci Rep; 2016 Oct; 6():31343. PubMed ID: 27694984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of tissue transglutaminase in tubular epithelial cells alters extracellular matrix levels: a potential mechanism of tissue scarring.
    Fisher M; Jones RA; Huang L; Haylor JL; El Nahas M; Griffin M; Johnson TS
    Matrix Biol; 2009 Jan; 28(1):20-31. PubMed ID: 19013523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase 2 interactions with extracellular matrix proteins as probed with celiac disease autoantibodies.
    Cardoso I; Stamnaes J; Andersen JT; Melino G; Iversen R; Sollid LM
    FEBS J; 2015 Jun; 282(11):2063-75. PubMed ID: 25808416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Syndecan-4 knockout leads to reduced extracellular transglutaminase-2 and protects against tubulointerstitial fibrosis.
    Scarpellini A; Huang L; Burhan I; Schroeder N; Funck M; Johnson TS; Verderio EA
    J Am Soc Nephrol; 2014 May; 25(5):1013-27. PubMed ID: 24357671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel extracellular role for tissue transglutaminase in matrix-bound VEGF-mediated angiogenesis.
    Wang Z; Perez M; Caja S; Melino G; Johnson TS; Lindfors K; Griffin M
    Cell Death Dis; 2013 Sep; 4(9):e808. PubMed ID: 24052076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of enigmatic transglutaminase 2 (TG2) in cardiac diseases and therapeutic developments.
    Al-U'datt DGF; Tranchant CC; Al-Dwairi A; Alqudah M; Al-Shboul O; Hiram R; Allen BG; Jaradat S; Alqbelat J; Abu-Zaiton AS
    Biochem Pharmacol; 2022 Jul; 201():115104. PubMed ID: 35617996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single conformational transglutaminase 2 epitope contributed by three domains is critical for celiac antibody binding and effects.
    Simon-Vecsei Z; Király R; Bagossi P; Tóth B; Dahlbom I; Caja S; Csosz É; Lindfors K; Sblattero D; Nemes É; Mäki M; Fésüs L; Korponay-Szabó IR
    Proc Natl Acad Sci U S A; 2012 Jan; 109(2):431-6. PubMed ID: 22198767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease.
    Chen X; Hnida K; Graewert MA; Andersen JT; Iversen R; Tuukkanen A; Svergun D; Sollid LM
    J Biol Chem; 2015 Aug; 290(35):21365-75. PubMed ID: 26160175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process.
    Fleckenstein B; Molberg Ø; Qiao SW; Schmid DG; von der Mülbe F; Elgstøen K; Jung G; Sollid LM
    J Biol Chem; 2002 Sep; 277(37):34109-16. PubMed ID: 12093810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl
    Engstrom N; Saenz-Méndez P; Scheers J; Scheers N
    Sci Rep; 2017 Mar; 7(1):77. PubMed ID: 28250436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase 2 has higher affinity for relaxed than for stretched fibronectin fibers.
    Selcuk K; Leitner A; Braun L; Le Blanc F; Pacak P; Pot S; Vogel V
    Matrix Biol; 2024 Jan; 125():113-132. PubMed ID: 38135164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of transglutaminase and ε (γ-glutamyl)-lysine in the Fisher-Lewis rat model of chronic allograft nephropathy.
    Shrestha B; Butt I; Da Silva M; Sanchez-Lara A; Wagner B; Raftery A; Johnson T; Haylor J
    Biomed Res Int; 2014; 2014():651608. PubMed ID: 25143942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue transglutaminase does not affect fibrotic matrix stability or regression of liver fibrosis in mice.
    Popov Y; Sverdlov DY; Sharma AK; Bhaskar KR; Li S; Freitag TL; Lee J; Dieterich W; Melino G; Schuppan D
    Gastroenterology; 2011 May; 140(5):1642-52. PubMed ID: 21277850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac fibrosis can be attenuated by blocking the activity of transglutaminase 2 using a selective small-molecule inhibitor.
    Wang Z; Stuckey DJ; Murdoch CE; Camelliti P; Lip GYH; Griffin M
    Cell Death Dis; 2018 Apr; 9(6):613. PubMed ID: 29795262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease.
    Da Silva Lodge M; Pullen N; Pereira M; Johnson TS
    PLoS One; 2022; 17(1):e0262104. PubMed ID: 35041708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope-dependent Functional Effects of Celiac Disease Autoantibodies on Transglutaminase 2.
    Hnida K; Stamnaes J; du Pré MF; Mysling S; Jørgensen TJ; Sollid LM; Iversen R
    J Biol Chem; 2016 Dec; 291(49):25542-25552. PubMed ID: 27784785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity-regulating structural changes and autoantibody epitopes in transglutaminase 2 assessed by hydrogen/deuterium exchange.
    Iversen R; Mysling S; Hnida K; Jørgensen TJ; Sollid LM
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17146-51. PubMed ID: 25404341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.